Search

Rss Posts

Rss Comments

Login

 

Posts in ‘tangerine’

Cancer Treatment: How Eating Fruit And Vegetables Can Improve Cancer Patients’ Response To Chemotherapy

Oct 29

ScienceDaily (Oct. 24, 2008) — The leading cause of death in all cancer patients continues to be the resistance of tumor cells to chemotherapy, a form of treatment in which chemicals are used to kill cells.

Now a study by UC Riverside biochemists that focuses on cancer cells reports that ingesting apigenin – a naturally occurring dietary agent found in vegetables and fruit – improves cancer cells’ response to chemotherapy.

Xuan Liu, a professor of biochemistry, and Xin Cai, a postdoctoral researcher working in her lab, found that apigenin localizes tumor suppressor p53, a protein, in the cell nucleus – a necessary step for killing the cell that results in some tumor cells responding to chemotherapy.

The study, published in the online early edition of the Proceedings of the National Academy of Sciences, provides a novel approach to conquer tumor resistance to chemotherapy, and suggests an avenue for developing safe chemotherapy via naturally occurring agents.

Normally, cells have low levels of p53 diffused in their cytoplasm and nucleus. When DNA in the nucleus is damaged, p53 moves to the nucleus where it activates genes that stop cell growth and cause cell death. In this way, p53 ensures that cells with damaged DNA are killed.

In many cancers, p53 is rendered inactive by a process called cytoplasmic sequestration. Apigenin is able to activate p53 and transport it into the nucleus, resulting in a stop to cell growth and cell death.

“In therapy you want to kill cancer cells,” explained Cai, the first author of the research paper. “But to stop cell growth and to kill the cell, p53 first needs to be moved to the cell’s nucleus to function. Apigenin is very effective in localizing p53 this way.”

Apigenin is mainly found in fruit (including apples, cherries, grapes), vegetables (including parsley, artichoke, basil, celery), nuts and plant-derived beverages (including tea and wine). It has been shown by researchers to have growth inhibitory properties in several cancer lines, including breast, colon, skin, thyroid and leukemia cells. It has also been shown to inhibit pancreatic cancer cell proliferation.

“Our study advocates the inclusion of vegetables and fruit in our daily diet to help prevent cancer,” said Liu, the research paper’s coauthor.

The National Institutes of Health supported the five-year study.

Next in their research Liu and Cai plan to design therapies for cancer by finding compounds that are like, but perform better than, apigenin.


Adapted from materials provided by University of California - Riverside

Tangerine peel could help fight cancer

Oct 16

“Tangerine peel could help fight cancer”, Reuters, September 12, 2007,
Link: http://www.reuters.com/article/healthNews/idUSL1110198320070912

Tangerine peel could help in the fight against certain cancers, researchers said on Wednesday.

Human cancer cells, which contain an enzyme called P450 CYP1B1, were destroyed by a compound contained in tangerine peel, Salvestrol Q40, scientists at Leicester School of Pharmacy found.

The findings may offer a new approach to uncovering a treatment for cancers such as breast, lung, prostate and ovarian cancer, the scientists said.

Medicinal chemist Dr. Hoon L. Tan said: “It is very exciting to find a compound in food that can target cancers specifically.

“Salvestrols may offer a new mechanism of dietary anti-cancer action.

“Indeed, the depletion of salvestrols in the modern diet is due to the fact that many people no longer eat the skin of fruits and this may be a major contributory factor to the increasing incidence of some cancers in the human population.”

The breakthrough was being presented at the British Pharmaceutical Conference held in Manchester.

But he warned that the research was still in its early days and many tests will be needed before reaching the clinical trial stage, which could take between five and seven years.

The researchers have formed a private company, Nature’s Defence Investments, to protect and promote their research, with the potential of designing a natural anti-cancer alternative based on the new technology.